Items per page
Sort by

Send to:

Choose Destination

Results: 9

Cited In for PubMed (Select 19022808)


Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.

Senabre-Gallego JM, Santos-Ramírez C, Santos-Soler G, Salas-Heredia E, Sánchez-Barrioluengo M, Barber X, Rosas J; AIRE-MB group.

Patient Prefer Adherence. 2013 Sep 23;7:961-72. doi: 10.2147/PPA.S33109. Review.


Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab.

Magiera M, Kopec-Medrek M, Widuchowska M, Kotulska A, Dziewit T, Ziaja D, Kucharz EJ, Logiewa-Bazger B, Mazur W.

Rheumatol Int. 2013 Jun;33(6):1611-3. doi: 10.1007/s00296-011-2262-7. Epub 2011 Dec 24.


Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists.

de Vries HS, van Oijen MG, Driessen RJ, de Jong EM, Creemers MC, Kievit W, de Jong DJ.

Br J Clin Pharmacol. 2011 Jan;71(1):7-19. doi: 10.1111/j.1365-2125.2010.03760.x.


microRNAs: critical regulators in Th17 cells and players in diseases.

Wei B, Pei G.

Cell Mol Immunol. 2010 May;7(3):175-81. doi: 10.1038/cmi.2010.19. Epub 2010 Apr 5. Review.


Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.

Rudwaleit M, Claudepierre P, Kron M, Kary S, Wong R, Kupper H.

Arthritis Res Ther. 2010;12(2):R43. doi: 10.1186/ar2953. Epub 2010 Mar 15.


Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.

Levine SJ, Wenzel SE.

Ann Intern Med. 2010 Feb 16;152(4):232-7. doi: 10.7326/0003-4819-152-4-201002160-00008. Review.


Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways.

Stein R, Gupta P, Chen X, Cardillo TM, Furman RR, Chen S, Chang CH, Goldenberg DM.

Blood. 2010 Jun 24;115(25):5180-90. doi: 10.1182/blood-2009-06-228288. Epub 2010 Jan 25.


Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8).

Zack MD, Melton MA, Stock JL, Storer CE, Barve RA, Minnerly JC, Weiss DJ, Stejskal JA, Tortorella MD, Turk JR, Shevlin KM, Malfait AM.

Clin Exp Immunol. 2009 Nov;158(2):246-56. doi: 10.1111/j.1365-2249.2009.04009.x. Epub 2009 Aug 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk